Formulary changes
Find 2020 Humana announcements for formulary changes and access the Medicare Drug List Search.
Effective January 1, 2020
Certain drugs will have new limitations or will require utilization management (e.g., prior authorization [PA] requirements, step therapy [ST] modifications and nonformulary [NF] changes) under the Humana Medicare formularies for the 2020 plan year. These changes could mean higher costs or new requirements for Humana members who use these drugs. Humana encourages the use of generic and cost-effective brand medications whenever possible.
Medicare formulary changes
Below are links to the top 10 drug changes by usage for each formulary beginning Jan. 1, 2020:
Search for prescription drugs online
Prescription drug information for Humana Medicare members and healthcare providers is available through the Medicare Drug List Search. Enter the applicable details to see the drug’s tier placement and restrictions that may apply.
If healthcare providers have questions regarding these changes, they may call 1-800-457-4708. This line is open Monday through Friday from 8 a.m. to 8 p.m. local time.
Pharmacy news
- Formulary changes
- Drug recall notice for metformin
- Drug recall notice for Nature-Throid and WP Thyroid tablets
- Drug recall notice for Belviq, Belviq XR (lorcaserin)
- Drug recall notice for NP Thyroid tablets
- Drug recall notice for Taro Pharmaceuticals phenytoin oral suspension
- Drug recall notice for nizatidine
- Ongoing ranitidine recalls
- Drug recall notice for Natpara
- Formulary changes for generic Ventolin HFA
- Formulary changes for generic Zytiga
- Impact of ongoing angiotensin II receptor blocker drug recalls
- Formulary changes
- Drug recall notice for metformin
- Drug recall notice for Nature-Throid and WP Thyroid tablets
- Drug recall notice for Belviq, Belviq XR (lorcaserin)
- Drug recall notice for NP Thyroid tablets
- Drug recall notice for Taro Pharmaceuticals phenytoin oral suspension
- Drug recall notice for nizatidine
- Ongoing ranitidine recalls
- Drug recall notice for Natpara
- Formulary changes for generic Ventolin HFA
- Formulary changes for generic Zytiga
- Impact of ongoing angiotensin II receptor blocker drug recalls